Continuous veno-venous hemodialysis with citrate anticoagulation using a dedicated dialysate

Continuous veno-venous hemodialysis with citrate anticoagulation using a dedicated dialysate - Continuous hemodialysis with citrate anticoagulation using a dedicated dialysate

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014911

Enrollment

Registered

2014-08-21

Start date

2014-08-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients 20 years of age or older for whom continuous hemodialysis is determined to be necessary

Interventions

Continuous hemodialysis with citrate anticoagulation between August 1, 2016 from August 1, 2014.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients 20 year-old or older for whom continuous hemodialysis is determined to be necessary, with agreement to participate in this study by the patient or his/her legal representative.

Exclusion criteria

Exclusion criteria: Severe liver failure cases

Design outcomes

Primary

Measure	Time frame
filter life	—

Secondary

Measure	Time frame
Occurrence of complications (metabolic alkalosis, hypocalcemia, hypernatremia, bleeding), arterial blood gases, Na+, iCa2+, dialysis conditions, number of dialysis membrane	—

Countries

Japan

Contacts

Public ContactShigehiko Uchino

Jikei University School of Medicine Intensive Care Unit, Department of Anesthesiology

s.uchino@mac.com03-3433-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026